Literature DB >> 12646315

[1-13C]Glucose entry in neuronal and astrocytic intermediary metabolism of aged rats. A study of the effects of nicergoline treatment by 13C NMR spectroscopy.

Alfredo Miccheli1, Caterina Puccetti, Giorgio Capuani, Maria Enrica Di Cocco, Luciana Giardino, Laura Calzà, Angelo Battaglia, Leontino Battistin, Filippo Conti.   

Abstract

Age-related changes in glucose utilization through the TCA cycle were studied using [1-13C]glucose and 13C, 1H NMR spectroscopy on rat brain extracts. Significant increases in lactate levels, as well as in creatine/phosphocreatine ratios (Cr/PCr), and a decrease in N-acetyl-aspartate (NAA) and aspartate levels were observed in aged rat brains as compared to adult animals following glucose administration. The total amount of 13C from [1-13C]glucose incorporated in glutamate, glutamine, aspartate and GABA was significantly decreased in control aged rat brains as compared to adult brains. The results showed a decrease in oxidative glucose utilization of control aged rat brains. The long-term nicergoline treatment increased NAA and glutamate levels, and decreased the lactate levels as well as the Cr/PCr ratios in aged rat brains as compared to adult rats. The total amount of 13C incorporated in glutamate, glutamine, aspartate, NAA and GABA was increased by nicergoline treatment, showing an improvement in oxidative glucose metabolism in aged brains. A significant increase in pyruvate carboxylase/pyruvate dehydrogenase activity (PC/PDH) in the synthesis of glutamate in nicergoline-treated aged rats is consistent with an increase in the transport of glutamine from glia to neurons for conversion into glutamate. In adult rat brains, no effect of nicergoline on glutamate PC/PDH activity was observed, although an increase in PC/PDH activity in glutamine was, suggesting that nicergoline affects the glutamate/glutamine cycle between neurons and glia in different ways depending on the age of animals. These results provide new insights into the effects of nicergoline on the CNS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646315     DOI: 10.1016/s0006-8993(02)04217-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Long-term exposure of variable dietary protein-to-carbohydrate ratio: effect on brain regional glutamatergic activity with age.

Authors:  Sudipta Pal; Mrinal K Poddar
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

Review 2.  Energy metabolism and inflammation in brain aging and Alzheimer's disease.

Authors:  Fei Yin; Harsh Sancheti; Ishan Patil; Enrique Cadenas
Journal:  Free Radic Biol Med       Date:  2016-05-03       Impact factor: 7.376

3.  Effects of Chronic Photobiomodulation with Transcranial Near-Infrared Laser on Brain Metabolomics of Young and Aged Rats.

Authors:  Fabrízio Dos Santos Cardoso; Júlio César Claudino Dos Santos; Francisco Gonzalez-Lima; Bruno Henrique Silva Araújo; Rodrigo Álvaro Brandão Lopes-Martins; Sérgio Gomes da Silva
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

4.  Alteration of interaction between astrocytes and neurons in different stages of diabetes: a nuclear magnetic resonance study using [1-(13)C]glucose and [2-(13)C]acetate.

Authors:  Na Wang; Liang-Cai Zhao; Yong-Quan Zheng; Min-Jian Dong; Yongchao Su; Wei-Jian Chen; Zi-Long Hu; Yun-Jun Yang; Hong-Chang Gao
Journal:  Mol Neurobiol       Date:  2014-07-22       Impact factor: 5.590

5.  Changes in Regional Cerebral Perfusion after Nicergoline Treatment in Early Alzheimer's Disease: A Pilot Study.

Authors:  Jooyeon J Im; Hyeonseok S Jeong; Jong-Sik Park; YoungSoon Yang; Seung-Hee Na; Jin Kyoung Oh; Yong-An Chung; In-Uk Song
Journal:  Dement Neurocogn Disord       Date:  2017-12-31

6.  Sesame Oil-Based Nanostructured Lipid Carriers of Nicergoline, Intranasal Delivery System for Brain Targeting of Synergistic Cerebrovascular Protection.

Authors:  Mohammed A S Abourehab; Ahmed Khames; Samar Genedy; Shahin Mostafa; Mohammad A Khaleel; Mahmoud M Omar; Amani M El Sisi
Journal:  Pharmaceutics       Date:  2021-04-19       Impact factor: 6.321

Review 7.  Brain Metabolic Alterations in Alzheimer's Disease.

Authors:  Carlos G Ardanaz; María J Ramírez; Maite Solas
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

Review 8.  Therapeutic use of nicergoline.

Authors:  Bengt Winblad; Mario Fioravanti; Tomas Dolezal; Inara Logina; Ivan Gospodinov Milanov; Dinu Cristian Popescu; Alina Solomon
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 3.580

9.  Cerebral Mitochondrial Function and Cognitive Performance during Aging: A Longitudinal Study in NMRI Mice.

Authors:  Martina Reutzel; Rekha Grewal; Benjamin Dilberger; Carmina Silaidos; Aljoscha Joppe; Gunter P Eckert
Journal:  Oxid Med Cell Longev       Date:  2020-04-13       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.